Consistently, ETP‐ALL exhibits high sensitivity to VEN; however, upregulation of MCL‐1 and its binding to released BIM following VEN exposure may mediate VEN resistance [44]. The gene discussed is BCL2L11; the disease is acute lymphoblastic leukemia.